RVX Chart by TradingView

Business Description

Resverlogix is a biotechnology company focused on the two largest drug markets – cancer and cholesterol. Its unique technology is focused on increasing HDL’s (good cholesterol) as opposed to the more common focus of lowering LDL’s (bad cholesterol).

Website: http://www.resverlogix.com/


Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19 Apr. 12, 2021
Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell Mar. 17, 2021
Apabetalone Treatment Prevents COVID-19 Infection of Human Lung Cells Mar. 15, 2021
Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA Mar. 15, 2021
Resverlogix Announces Change in Fiscal Year-End to December 31 Mar. 12, 2021